Comorbidities Related to BMI Category in Children and Adolescents: German/Austrian/Swiss Obesity Register APV Compared to the German KiGGS StudyFlechtner-Mors M.a · Thamm M.b · Wiegand S.c · Reinehr T.d · Schwab K.O.e · Kiess W.f · Widhalm K.g · Holl R.W.a · for the APV initiative and the BMBF Competence Network Obesity
aInstitute of Epidemiology and Medical Biometry, University of Ulm, Ulm, bRobert Koch Institute, and cCharité Children's Hospital, Humboldt University Berlin, Berlin, dDepartment of Pediatric Endocrinology, Diabetes and Nutrition Medicine, University of Witten/Herdecke, Witten/Herdecke, eDepartment of Pediatrics and Adolescent Medicine, University Hospital, Freiburg, and fUniversity Hospital for Children and Adolescents, Leipzig, Germany; gDepartment of Pediatrics, University of Vienna, Vienna, Austria
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Purpose: To assess cardiovascular risk factors in overweight or obese children and adolescents in Germany, Austria and Switzerland and to investigate the relationship to BMI category. Methods: Data of 63,025 overweight or obese patients (APV population) were compared to normal-weight subjects from a representative study on health status of 14,298 children and adolescents in Germany (KiGGS survey). The weight status was assessed by BMI, and BMI-SDS values were cal-culated using national reference data. Results: In normal-weight KiGGS subjects, mean BMI was 17.3 ± 2.5 (BMI-SDS -0.1 ± 0.8). In the overweight or obese APV population, mean BMI was 30.2 ± 5.6 (BMI-SDS 2.5 ± 0.6). In normal-weight subjects blood pressure, total cholesterol, LDL-cholesterol, and triglycerides were elevated in 6.1, 8.6, 7.0 and 3.0%, respectively, and HDL-cholesterol was reduced in 3.0%, whereas in overweight/obese subjects the percentages of abnormal values were 35.3, 13.8, 14.5, 13.6, and 10.1%, respectively. Conclusions: Cardiovascular risk is increased in obese children and adolescents. There is a strong need to monitor blood pressure and serum lipids in this group of patients. Our results emphasize the importance of prevention of obesity in order to reduce cardiovascular risk.
© 2011 S. Karger AG, Basel
- Wang Y, Lobstein T: Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 2006;1:11-25.
- Ogden CL, Caroll MD, Curtin LR, Lamb MM, Flegal KM: Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 2010;303:242-249.
- Blüher S, Meigen C, Gausche R, Keller E, Pfäffle R, Sabin M, Werther G, Odeh R, Kiess W: Age-specific stabilization in obesity prevalence in German children: a cross-sectional study from 1999 to 2008. Int J Pediatr Obes 2011;6:e199-206.
- Reinehr T, Andler W, Denzer C, Siegfried C, Siegried W, Mayer H, Wabitsch M: Cardiovascular risk factors in overweight German children and adolescents: relation to gender, age and degree of overweight. Nutr Metab Cardiovasc Dis 2005;15:181-187.
- Founian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, Girardet JP, Bonnet D: Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001;358:1400-1404.
- Singhal A, Farooqi IS, Cole TJ, O'Rahilly S, Fewtrell M, Kattenhorn M, Lucas A, Deanfield J: Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 2002;106:1919-1924.
Mittelman SD, Gilsanz P, Mo AO, Wood J, Dorey F, Gilsanz V: Adiposity predicts carotid intima-media thickness in healthy children and adolescents: J Pediatr 2010;156:592-597.e2.
- Baker JL, Olsen LW, Sørensen TI: Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007;357:2329-2337.
- Franks PW, Hanson RL, Knowler WC, Sie-vers ML, Bennet PH, Looker HC: Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010;362:485-493.
- Lawlor DA, Martin RM, Gunnell D, Galobardes B, Ebrahim S, Sandh J, Ben-Shlomo Y, McCarron P, Davey Smith G: Association of body mass index measured in childhood, adolescence, and young adulthood with risk of ischemic heart disease and stroke: findings from 3 historical cohort studies. Am J Clin Nutr 2006;83:767-773.
- Lloyd LJ, Langley-Evans SC, McMullen S: Childhood obesity and adult cardiovascular disease risk: a systematic review. Int J Obes 2010;34:474-488.
- Singh AS, Mulder C, Twisk JWR, van Me-chelen W, Chinapaw MJM: Tracking of childhood overweight into adulthood: a systematic review of the literature. Obes Rev 2008;9:474-488.
- Reinehr T, Wabitsch M, Andler W, et al: Medical care of obese children and adolescents - APV: a standardised multicentre documentation derived to study initial presentation and cardiovascular risk factors in patients transferred to specialised treatment institutions. Eur J Pediatr 2004;163:308-312.
Kurth BM: Der Kinder- und Jugendgesundheitssurvey (KiGGS): Ein Überblick über Planung, Durchführung und Ergebnisse unter Berücksichtigung von Aspekten eines Qualitätsmanagements. Bundesgesundheitsbl Gesundheitsforsch Gesundheits-schutz 2007;50:533-546.
Kromeyer-Hausschild K, Wabitsch M, Kunze D, Geller F, Geiss HC, Hesse V, von Hippel A, Jaeger U, Johsen D, Korte W, Menner K, Müller G, Müller JM, Niemann-Pielatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Ziegler A, Hebebrand J: Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinder-heilkd 2001;149:807-818.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: the fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents - National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 2004;114:555-576.
- Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, Kuznetsova T, Laurent S, Mancia G, Morales-Olivas F, Rascher W, Redon J, Schaefer F, Seeman T, Stergiou G, Wühl E, Zanchetti: Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009;27:1719-1742.
Bundesärztekammer: Richtlinie der Bun-desärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen. Dtsch Ärzteblatt 2009;105:A341-355.
- Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K: American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 2003;107:1562-1566.
- L'Allemand-Jander D, Wiegand S, Reinehr T, Müller J, Wabitsch M, Widhalm K, Holl R, APV Study Group: Cardiovascular risk in 26,008 European overweight children as established by a multicenter database. Obesity 2008;16:1672-1679.
- Lambert M, Delvin EE, Levy E, O'Loughlin J, Paradis G, Barnett T, McGrath JJ: Prevalence of cardiometabolic risk factors by weight status in a population-based sample of Quebec children and adolescents. Can J Cardiol 2008;24:575-583.
- Ice CL, Cotrell L, Neal WA: Body mass index as a surrogate measure of cardiovascular risk factor clustering in fifth-grade children: results from the coronary artery risk detection in the Appalachian Communities Project. Int J Pediatr Obes 2009;4:316-324.
- Muntner P, He J, Cutler JA, Wildman PR, Whelton PK: Trends in blood pressure among children and adolescents. JAMA 2004;291:2107-2113.
- Din-Dzietham R, Liu Y, Bielo M-V, Shamsa F: High blood pressure trends in children and adolescents in national surveys, 1963-2002. Circulation 2007;116:1488-1496.
- Chen X, Wang Y: Tracking of blood pressure from childhood to adulthood. Circulation 2008;117:3171-3180.
- Toschke AM, Kohl L, Mansman U, von Kries R: Meta-analysis of blood pressure tracking from childhood to adulthood and implications for the design of intervention trials. Acta Paediatr 2010;99:24-29.
- Kneer I, Dost A, Lepler R, Raile K, Schober E, Rascher W, Holl RW, DPV Study Group: Tracking and prediction of arterial blood pressure from childhood to young adulthood in 868 patients with type 1 diabetes. Diabetes Care 2008;31:726-727.
- Woo KS, Ckook P, Yu CW, Sung RY, Oiao M, Leung SS, Lam CW, Metreweli C, Celemajer DS: Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int J Obes Relat Metab Disord 2004;27:852-857.
- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
- Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-2367.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.